Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Tzu-Hsuan Chiu"'
Autor:
Jia-Shiuan Ju, Allen Chung-Cheng Huang, Pi-Hung Tung, Chi-Hsien Huang, Tzu-Hsuan Chiu, Chin-Chou Wang, How-Wen Ko, Fu-Tsai Chung, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutation is brain metastasis (BM)-prone. We determined the impact of this hallmark, along with EGFR subtype and generation of tyrosine kinase inhibitor (TKI) tre
Externí odkaz:
https://doaj.org/article/bce3fbab037c45f29c24a461f2f07a28
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC
Autor:
Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang, Jia-Shiuan Ju, Chi-Hsien Huang, Chin-Chou Wang, How-Wen Ko, Fu-Tsai Chung, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Substitution of methionine for threonine at codon 790 (T790M) of epidermal growth factor receptor (EGFR) represents the major mechanism of resistance to EGFR tyrosine kinase inhibitors (TKIs) in EGFR -mutant non-small-cell lung cancer. We
Externí odkaz:
https://doaj.org/article/cb59f58b72a54d5aa11a70e91bdabd7a
Autor:
Shu-Min Lin, Chung-Shu Lee, Allen Chung-Cheng Huang, Tzu-Hsuan Chiu, Ko-Wei Chang, Tse-Hung Huang, Tsung-Hsien Yang, Yi-Hsien Shiao, Fu-Tsai Chung, Chyi-Liang Chen, Cheng-Hsun Chiu
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 257-264 (2023)
Objectives: This study explored the outcomes and predictors of early viral clearance among patients with COVID-19. Methods: This study recruited consecutive patients from March 1, 2020 to July 31, 2021. Early viral clearance was defined as having a d
Externí odkaz:
https://doaj.org/article/44838a1c18134fcbaf38372d2ae476d1
Autor:
Shu-Min Lin, Allen Chung-Cheng Huang, Tzu-Hsuan Chiu, Ko-Wei Chang, Tse-Hung Huang, Tsung-Hsien Yang, Yi-Hsien Shiao, Chung-Shu Lee, Fu-Tsai Chung, Chyi-Liang Chen, Cheng-Hsun Chiu
Publikováno v:
Biomedical Journal, Vol 46, Iss 1, Pp 100-109 (2023)
Background: Reliable clinical and laboratory predictors of coronavirus disease 2019 (COVID-19) disease progression could help to identify the subset of patients who are susceptible to severe symptoms. This study sought to identify the predictors for
Externí odkaz:
https://doaj.org/article/b02eb6aed0bf4ab5b00b681e25fa85db
Autor:
Chiung-Hung Lin, Jih-Kai Yeh, Ting-Yu Lin, Yu-Lun Lo, Bo-Jui Chang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, Pi-Hung Tung, Yun-Ju Huang, Shu-Min Lin
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Heart failure with reduced ejection fraction (HFrEF) can coexist with chronic obstructive pulmonary disease (COPD), which complicates the clinical situation and worsens quality of life. The study used standard diagnostic criteria
Externí odkaz:
https://doaj.org/article/e035ffc795734e5c9527a7c535b8f1ce
Autor:
Tzu-Hsuan Chiu, Pi-Hung Tung, Chi-Hsien Huang, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Chin-Chou Wang, Ho-Wen Ko, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Comparison of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) monotherapy or with bevacizumab in real-world non-small cell lung cancer (NSCLC) patients was lacking. 310 patients of advanced NSCLC with common EGFR mutati
Externí odkaz:
https://doaj.org/article/17eff21402b64752921f6d7b503a59e8
Autor:
Hung-Yu Huang, Chung-Shu Lee, Tzu-Hsuan Chiu, Hsiang Hsuan Chen, Li-Yi Chan, Chee-Jen Chang, Shu-Chen Chang, Han-Chung Hu, Kuo-Chin Kao, Ning-Hung Chen, Shu-Min Lin, Li-Fu Li
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 1, Pp 162-169 (2022)
Background/Purpose: Neurological dysfunction is a common condition necessitating prolonged mechanical ventilation (PMV). We investigated the clinical features and outcomes of patients with acute neurological diseases requiring PMV. Methods: This retr
Externí odkaz:
https://doaj.org/article/b6a0a9b767764384bd7d773fec62095e
Autor:
Chia‐Hsun Chu, Tzu‐Hsuan Chiu, Chin‐Chou Wang, Wen‐Chen Chang, Allen Chung‐Cheng Huang, Chien‐Ying Liu, Chih‐Liang Wang, Ho‐Wen Ko, Fu‐Tsai Chung, Ping‐Chih Hsu, Yi‐Ke Guo, Chih‐Hsi S. Kuo, Cheng‐Ta Yang
Publikováno v:
Thoracic Cancer, Vol 11, Iss 6, Pp 1541-1549 (2020)
Background Treatment for stage III non‐small cell lung cancer (NSCLC) of unresectable disease mainly involves concurrent chemoradiation (CRT). Post‐CRT consolidation treatment with durvalumab is a major therapeutic advance that provides survival
Externí odkaz:
https://doaj.org/article/521f162d13944edf8763192c7fba81bd
Autor:
Allen Chung-Cheng Huang, Chi-Hsien Huang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, Pi-Hung Tung, Chin-Chou Wang, Chien-Ying Liu, Fu-Tsai Chung, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: There are limited comparisons of first- and second-generation EGFR tyrosine kinase inhibitors (TKIs) in large, real-world cohorts of non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor ( EGFR ) mutations. Met
Externí odkaz:
https://doaj.org/article/763e57c256f446a5b609a81341cda010
Publikováno v:
Medicina, Vol 57, Iss 9, p 967 (2021)
Background and Objectives: Patients who have advanced lung cancer and bone metastasis (BM) often suffer from skeletal-related events (SREs) that lead to poor quality of life and poor prognosis. Our study aimed to investigate the prognostic factors in
Externí odkaz:
https://doaj.org/article/7ee511813a634ad9be85903a34049cb0